David Chien Lye

机构：Agency for Science, Technology and Research, National Environment Agency, National University of Singapore, Nanyang Technological University, Tan Tock Seng Hospital, National Centre for Infectious Diseases · ORCID：0000-0003-0324-0205

发表论文 588 篇 · 总被引 45610 次 · h-index 81

代表论文

• Cefiderocol versus standard therapy for hospital-acquired and health-care-associated Gram-negative bacterial bloodstream infection (the GAME CHANGER trial): an open-label, parallel-group, randomised trial (2025 · The Lancet Infectious Diseases · 被引 18)
• Quantifying the impact of a broadly protective sarbecovirus vaccine in a future SARS-X pandemic (2025 · Nature Communications · 被引 9)
• Neurological Events Associated With Acute Dengue Infection (2025 · JAMA Neurology · 被引 5)
• Core outcome measurement set for clinical trials in dengue: an international Delphi consensus study (DEN-CORE) (2025 · The Lancet Infectious Diseases · 被引 5)
• Modeling Antibody Kinetics Post‐mRNA Booster Vaccination and Protection Durations Against SARS‐CoV‐2 Infection (2025 · Journal of Medical Virology · 被引 4)
• Cardiovascular complications in acute dengue infection: a population-based cohort study (2025 · The Lancet Regional Health - Western Pacific · 被引 3)